Abiopharma

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001306 Size: 30 KB

New Form SCHEDULE 13D/A - AVENUE THERAPEUTICS, INC. Filed: 2026-01-06 AccNo: 0001104659-26-001305 Size: 14 KB

Director RYAN ARTHUR F 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Director COLES N ANTHONY 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

(99% Neutral) Regional Health Properties, Inc. (RHE$A) Announces Regulatory Update

Bragg Kimberly 🟢 acquired 9.1K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000615

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001303 Size: 30 KB

📋 Badawi Paul (Officer) plans to sell 12K shares of Sight Sciences, Inc. (at $7.48 each, total $89K) Filed: Jan 06, 2026 | ID: 000149

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Cowan Chad 🔴 sold 1.6K shares of Century Therapeutics, Inc. (IPSC) at $0.99 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director Smith Jill D. 🟢 acquired 23.1K shares of Evolent Health, Inc. (EVH) Transaction Date: Jan 02, 2026 | Filing ID: 000006

Duker Jay S. 🟡 adjusted position in 458.0K shares (4 derivative) of EyePoint, Inc. (EYPT) at $17.48 ($6.4M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001300 Size: 30 KB

Director BROWN MICHAEL S 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002